← Back to BRNS

Barinthus Biotherapeutics plc - American Depositary Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 30/04/2026Sep 2025Filed 07/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 30/04/2026Sep 2024Filed 07/11/2025Jun 2024Filed 07/08/2025Mar 2024Filed 07/05/2025
$0$15$0$0
−$11−$5.5−$15−$21−$20−$8.1−$17−$15
−$0.26−$0.14−$0.36−$0.52−$0.49−$0.21−$0.43−$0.40
4141414040393939

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.